Cancer vaccines and immunotherapy:
Rapid progress in the definition of tumour antigens, and improved immunisation methods, bring effective cancer vaccines within reach. In this wide-ranging survey, clinicians and scientists at the forefront of these developments review therapeutic cancer vaccine strategies against a variety of diseas...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2000
|
| Schlagworte: | |
| Online-Zugang: | BSB01 FHN01 Volltext |
| Zusammenfassung: | Rapid progress in the definition of tumour antigens, and improved immunisation methods, bring effective cancer vaccines within reach. In this wide-ranging survey, clinicians and scientists at the forefront of these developments review therapeutic cancer vaccine strategies against a variety of diseases and molecular targets. Intended for an interdisciplinary readership, chapters cover the rationale, development and implementation of vaccines in human cancers generally, and with specific reference to cancer of the cervix, breast, colon, bladder, and prostate, and to melanoma and lymphoma. Target identification, delivery vectors and clinical trial design are reviewed, and the book begins and ends with lucid overviews from the editors, including the most recent developments. Encapsulating recent scientific progress and the likely clinical potential of cancer vaccines, this book provides an essential introduction and guide for oncologists, immunologists and indeed all clinicians treating cancer patients |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
| Beschreibung: | 1 online resource (x, 286 pages) |
| ISBN: | 9780511527098 |
| DOI: | 10.1017/CBO9780511527098 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043942604 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161206s2000 |||| o||u| ||||||eng d | ||
| 020 | |a 9780511527098 |c Online |9 978-0-511-52709-8 | ||
| 024 | 7 | |a 10.1017/CBO9780511527098 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9780511527098 | ||
| 035 | |a (OCoLC)849903168 | ||
| 035 | |a (DE-599)BVBBV043942604 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-92 | ||
| 082 | 0 | |a 616.99/406 |2 21 | |
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Cancer vaccines and immunotherapy |c edited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll |
| 246 | 1 | 3 | |a Cancer Vaccines & Immunotherapy |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2000 | |
| 300 | |a 1 online resource (x, 286 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
| 505 | 8 | 0 | |t Immunity and cancer |r Peter C.L. Beverley, Miles W. Carroll, Peter L. Sterm |t Immunotherapy of bladder cancer |r Anton B. Alexandroff, Keith James |t Poxviruses as vectors for cancer immunotherapy |r Miles W. Carroll, Nicholas P. Restifo |t Vaccinia-based human papillomavirus vaccines in cervical cancer |r Leszek K. Borysiewicz, Stephen Man |t Vaccine delivery and immunosuppression in cervical cancer |r Michael P. Rudolf, Laurie A. Small, Markwin P. Velders, Diane M. DaSilva, Sanne Weijzen, W. Martin Kast |t Vaccines for colon cancer |r Howard L. Kaufman, Jeffrey Schlom |t MUC1 vaccines and breast cancer |r Joyce Taylor-Papadimitriou, Joy Burchell, David W. Miles |t Anti-idiotypic vaccination |r Lindy G. Durrant, Ian Spendlove, R. Adrian Robins |t Immunotherapy and vaccination against Epstein-Barr virus-associated cancer |r John R. Arrand |t Serologically identified tumour antigens as cancer vaccines |r Ugur Sahin, Ozlem Tureci, Michael Pfreundschuh |t CTL-defined cancer vaccines in melanoma and other epithelial cancers |r Elke Jager, Dirk Jager, Alexander Knuth |t DNA vaccines against B-cell tumours |r Freda K. Stevenson, Delin Zhu, Myfanwy Spellerberg, Catherine A. King, Surinder S. Sahota, Jason Rice, Andrew R. Thompsett, Terry J. Hamblin |t Dendritic cell approaches to immunotherapy |r Malcolm Adams, Bharat Jasani, Camilo A.L.S. Colaco, Malcolm D. Mason |t Overview |r Peter L. Stern, Peter C.L. Beverley, Miles W. Carroll |t Recent developments |r Peter L. Stern |
| 520 | |a Rapid progress in the definition of tumour antigens, and improved immunisation methods, bring effective cancer vaccines within reach. In this wide-ranging survey, clinicians and scientists at the forefront of these developments review therapeutic cancer vaccine strategies against a variety of diseases and molecular targets. Intended for an interdisciplinary readership, chapters cover the rationale, development and implementation of vaccines in human cancers generally, and with specific reference to cancer of the cervix, breast, colon, bladder, and prostate, and to melanoma and lymphoma. Target identification, delivery vectors and clinical trial design are reviewed, and the book begins and ends with lucid overviews from the editors, including the most recent developments. Encapsulating recent scientific progress and the likely clinical potential of cancer vaccines, this book provides an essential introduction and guide for oncologists, immunologists and indeed all clinicians treating cancer patients | ||
| 650 | 4 | |a Cancer vaccines | |
| 650 | 4 | |a Cancer / Immunotherapy | |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | 2 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Stern, Peter L. |4 edt | |
| 700 | 1 | |a Beverley, Peter C. L. |4 edt | |
| 700 | 1 | |a Carroll, Miles W. |d 1965- |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-62263-9 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/CBO9780511527098 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029351574 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511527098 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511527098 |l FHN01 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176885665497088 |
|---|---|
| any_adam_object | |
| author2 | Stern, Peter L. Beverley, Peter C. L. Carroll, Miles W. 1965- |
| author2_role | edt edt edt |
| author2_variant | p l s pl pls p c l b pcl pclb m w c mw mwc |
| author_additional | Peter C.L. Beverley, Miles W. Carroll, Peter L. Sterm Anton B. Alexandroff, Keith James Miles W. Carroll, Nicholas P. Restifo Leszek K. Borysiewicz, Stephen Man Michael P. Rudolf, Laurie A. Small, Markwin P. Velders, Diane M. DaSilva, Sanne Weijzen, W. Martin Kast Howard L. Kaufman, Jeffrey Schlom Joyce Taylor-Papadimitriou, Joy Burchell, David W. Miles Lindy G. Durrant, Ian Spendlove, R. Adrian Robins John R. Arrand Ugur Sahin, Ozlem Tureci, Michael Pfreundschuh Elke Jager, Dirk Jager, Alexander Knuth Freda K. Stevenson, Delin Zhu, Myfanwy Spellerberg, Catherine A. King, Surinder S. Sahota, Jason Rice, Andrew R. Thompsett, Terry J. Hamblin Malcolm Adams, Bharat Jasani, Camilo A.L.S. Colaco, Malcolm D. Mason Peter L. Stern, Peter C.L. Beverley, Miles W. Carroll Peter L. Stern |
| author_facet | Stern, Peter L. Beverley, Peter C. L. Carroll, Miles W. 1965- |
| building | Verbundindex |
| bvnumber | BV043942604 |
| classification_rvk | XH 3200 |
| collection | ZDB-20-CBO |
| contents | Immunity and cancer Immunotherapy of bladder cancer Poxviruses as vectors for cancer immunotherapy Vaccinia-based human papillomavirus vaccines in cervical cancer Vaccine delivery and immunosuppression in cervical cancer Vaccines for colon cancer MUC1 vaccines and breast cancer Anti-idiotypic vaccination Immunotherapy and vaccination against Epstein-Barr virus-associated cancer Serologically identified tumour antigens as cancer vaccines CTL-defined cancer vaccines in melanoma and other epithelial cancers DNA vaccines against B-cell tumours Dendritic cell approaches to immunotherapy Overview Recent developments |
| ctrlnum | (ZDB-20-CBO)CR9780511527098 (OCoLC)849903168 (DE-599)BVBBV043942604 |
| dewey-full | 616.99/406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/406 |
| dewey-search | 616.99/406 |
| dewey-sort | 3616.99 3406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1017/CBO9780511527098 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04613nmm a2200553zc 4500</leader><controlfield tag="001">BV043942604</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161206s2000 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511527098</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-511-52709-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9780511527098</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9780511527098</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)849903168</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043942604</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/406</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer vaccines and immunotherapy</subfield><subfield code="c">edited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Cancer Vaccines & Immunotherapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (x, 286 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2="0"><subfield code="t">Immunity and cancer</subfield><subfield code="r">Peter C.L. Beverley, Miles W. Carroll, Peter L. Sterm</subfield><subfield code="t">Immunotherapy of bladder cancer</subfield><subfield code="r">Anton B. Alexandroff, Keith James</subfield><subfield code="t">Poxviruses as vectors for cancer immunotherapy</subfield><subfield code="r">Miles W. Carroll, Nicholas P. Restifo</subfield><subfield code="t">Vaccinia-based human papillomavirus vaccines in cervical cancer</subfield><subfield code="r">Leszek K. Borysiewicz, Stephen Man</subfield><subfield code="t">Vaccine delivery and immunosuppression in cervical cancer</subfield><subfield code="r">Michael P. Rudolf, Laurie A. Small, Markwin P. Velders, Diane M. DaSilva, Sanne Weijzen, W. Martin Kast</subfield><subfield code="t">Vaccines for colon cancer</subfield><subfield code="r">Howard L. Kaufman, Jeffrey Schlom</subfield><subfield code="t">MUC1 vaccines and breast cancer</subfield><subfield code="r">Joyce Taylor-Papadimitriou, Joy Burchell, David W. Miles</subfield><subfield code="t">Anti-idiotypic vaccination</subfield><subfield code="r">Lindy G. Durrant, Ian Spendlove, R. Adrian Robins</subfield><subfield code="t">Immunotherapy and vaccination against Epstein-Barr virus-associated cancer</subfield><subfield code="r">John R. Arrand</subfield><subfield code="t">Serologically identified tumour antigens as cancer vaccines</subfield><subfield code="r">Ugur Sahin, Ozlem Tureci, Michael Pfreundschuh</subfield><subfield code="t">CTL-defined cancer vaccines in melanoma and other epithelial cancers</subfield><subfield code="r">Elke Jager, Dirk Jager, Alexander Knuth</subfield><subfield code="t">DNA vaccines against B-cell tumours</subfield><subfield code="r">Freda K. Stevenson, Delin Zhu, Myfanwy Spellerberg, Catherine A. King, Surinder S. Sahota, Jason Rice, Andrew R. Thompsett, Terry J. Hamblin</subfield><subfield code="t">Dendritic cell approaches to immunotherapy</subfield><subfield code="r">Malcolm Adams, Bharat Jasani, Camilo A.L.S. Colaco, Malcolm D. Mason</subfield><subfield code="t">Overview</subfield><subfield code="r">Peter L. Stern, Peter C.L. Beverley, Miles W. Carroll</subfield><subfield code="t">Recent developments</subfield><subfield code="r">Peter L. Stern</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Rapid progress in the definition of tumour antigens, and improved immunisation methods, bring effective cancer vaccines within reach. In this wide-ranging survey, clinicians and scientists at the forefront of these developments review therapeutic cancer vaccine strategies against a variety of diseases and molecular targets. Intended for an interdisciplinary readership, chapters cover the rationale, development and implementation of vaccines in human cancers generally, and with specific reference to cancer of the cervix, breast, colon, bladder, and prostate, and to melanoma and lymphoma. Target identification, delivery vectors and clinical trial design are reviewed, and the book begins and ends with lucid overviews from the editors, including the most recent developments. Encapsulating recent scientific progress and the likely clinical potential of cancer vaccines, this book provides an essential introduction and guide for oncologists, immunologists and indeed all clinicians treating cancer patients</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer vaccines</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Immunotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stern, Peter L.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Beverley, Peter C. L.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carroll, Miles W.</subfield><subfield code="d">1965-</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-62263-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9780511527098</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029351574</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511527098</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511527098</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043942604 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:39:18Z |
| institution | BVB |
| isbn | 9780511527098 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029351574 |
| oclc_num | 849903168 |
| open_access_boolean | |
| owner | DE-12 DE-92 |
| owner_facet | DE-12 DE-92 |
| physical | 1 online resource (x, 286 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Cancer vaccines and immunotherapy edited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll Cancer Vaccines & Immunotherapy Cambridge Cambridge University Press 2000 1 online resource (x, 286 pages) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 05 Oct 2015) Immunity and cancer Peter C.L. Beverley, Miles W. Carroll, Peter L. Sterm Immunotherapy of bladder cancer Anton B. Alexandroff, Keith James Poxviruses as vectors for cancer immunotherapy Miles W. Carroll, Nicholas P. Restifo Vaccinia-based human papillomavirus vaccines in cervical cancer Leszek K. Borysiewicz, Stephen Man Vaccine delivery and immunosuppression in cervical cancer Michael P. Rudolf, Laurie A. Small, Markwin P. Velders, Diane M. DaSilva, Sanne Weijzen, W. Martin Kast Vaccines for colon cancer Howard L. Kaufman, Jeffrey Schlom MUC1 vaccines and breast cancer Joyce Taylor-Papadimitriou, Joy Burchell, David W. Miles Anti-idiotypic vaccination Lindy G. Durrant, Ian Spendlove, R. Adrian Robins Immunotherapy and vaccination against Epstein-Barr virus-associated cancer John R. Arrand Serologically identified tumour antigens as cancer vaccines Ugur Sahin, Ozlem Tureci, Michael Pfreundschuh CTL-defined cancer vaccines in melanoma and other epithelial cancers Elke Jager, Dirk Jager, Alexander Knuth DNA vaccines against B-cell tumours Freda K. Stevenson, Delin Zhu, Myfanwy Spellerberg, Catherine A. King, Surinder S. Sahota, Jason Rice, Andrew R. Thompsett, Terry J. Hamblin Dendritic cell approaches to immunotherapy Malcolm Adams, Bharat Jasani, Camilo A.L.S. Colaco, Malcolm D. Mason Overview Peter L. Stern, Peter C.L. Beverley, Miles W. Carroll Recent developments Peter L. Stern Rapid progress in the definition of tumour antigens, and improved immunisation methods, bring effective cancer vaccines within reach. In this wide-ranging survey, clinicians and scientists at the forefront of these developments review therapeutic cancer vaccine strategies against a variety of diseases and molecular targets. Intended for an interdisciplinary readership, chapters cover the rationale, development and implementation of vaccines in human cancers generally, and with specific reference to cancer of the cervix, breast, colon, bladder, and prostate, and to melanoma and lymphoma. Target identification, delivery vectors and clinical trial design are reviewed, and the book begins and ends with lucid overviews from the editors, including the most recent developments. Encapsulating recent scientific progress and the likely clinical potential of cancer vaccines, this book provides an essential introduction and guide for oncologists, immunologists and indeed all clinicians treating cancer patients Cancer vaccines Cancer / Immunotherapy Immuntherapie (DE-588)4026640-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Impfstoff (DE-588)4026655-2 s Immuntherapie (DE-588)4026640-0 s 1\p DE-604 Stern, Peter L. edt Beverley, Peter C. L. edt Carroll, Miles W. 1965- edt Erscheint auch als Druckausgabe 978-0-521-62263-9 https://doi.org/10.1017/CBO9780511527098 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Cancer vaccines and immunotherapy Immunity and cancer Immunotherapy of bladder cancer Poxviruses as vectors for cancer immunotherapy Vaccinia-based human papillomavirus vaccines in cervical cancer Vaccine delivery and immunosuppression in cervical cancer Vaccines for colon cancer MUC1 vaccines and breast cancer Anti-idiotypic vaccination Immunotherapy and vaccination against Epstein-Barr virus-associated cancer Serologically identified tumour antigens as cancer vaccines CTL-defined cancer vaccines in melanoma and other epithelial cancers DNA vaccines against B-cell tumours Dendritic cell approaches to immunotherapy Overview Recent developments Cancer vaccines Cancer / Immunotherapy Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd Impfstoff (DE-588)4026655-2 gnd |
| subject_GND | (DE-588)4026640-0 (DE-588)4073781-0 (DE-588)4026655-2 |
| title | Cancer vaccines and immunotherapy |
| title_alt | Cancer Vaccines & Immunotherapy Immunity and cancer Immunotherapy of bladder cancer Poxviruses as vectors for cancer immunotherapy Vaccinia-based human papillomavirus vaccines in cervical cancer Vaccine delivery and immunosuppression in cervical cancer Vaccines for colon cancer MUC1 vaccines and breast cancer Anti-idiotypic vaccination Immunotherapy and vaccination against Epstein-Barr virus-associated cancer Serologically identified tumour antigens as cancer vaccines CTL-defined cancer vaccines in melanoma and other epithelial cancers DNA vaccines against B-cell tumours Dendritic cell approaches to immunotherapy Overview Recent developments |
| title_auth | Cancer vaccines and immunotherapy |
| title_exact_search | Cancer vaccines and immunotherapy |
| title_full | Cancer vaccines and immunotherapy edited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll |
| title_fullStr | Cancer vaccines and immunotherapy edited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll |
| title_full_unstemmed | Cancer vaccines and immunotherapy edited by Peter L. Stern, Peter C.L. Beverley, and Miles W. Carroll |
| title_short | Cancer vaccines and immunotherapy |
| title_sort | cancer vaccines and immunotherapy |
| topic | Cancer vaccines Cancer / Immunotherapy Immuntherapie (DE-588)4026640-0 gnd Krebs Medizin (DE-588)4073781-0 gnd Impfstoff (DE-588)4026655-2 gnd |
| topic_facet | Cancer vaccines Cancer / Immunotherapy Immuntherapie Krebs Medizin Impfstoff |
| url | https://doi.org/10.1017/CBO9780511527098 |
| work_keys_str_mv | AT sternpeterl cancervaccinesandimmunotherapy AT beverleypetercl cancervaccinesandimmunotherapy AT carrollmilesw cancervaccinesandimmunotherapy AT sternpeterl cancervaccinesimmunotherapy AT beverleypetercl cancervaccinesimmunotherapy AT carrollmilesw cancervaccinesimmunotherapy |